生活習慣病領域における創薬ベンチャーである当社の特徴は、潤沢な開発パイプラインと、化合物創製・薬効評価・臨床開発等の創薬の専門性を有し医薬品開発のトラックレコードを持つ研究開発チームにあります。
Investors 1
Mentions in press and media 2
| Date | Title | Description |
| 29.09.2020 | Yokohama joins Maryland Life Sciences’ Bio Innovation Conference through Kanagawa virtual trade delegation | Three Yokohama-based companies will be participating in this year’s Bio Innovation Conference, hosted by Maryland Life Sciences, a division of the Maryland Tech Council. The startups will be joining through a trade mission sponsored by Kana... |
| - | Scohia Pharma | “As a drug discovery venture in the field of lifestyle・related diseases, we are characterized by a rich development pipeline and a R&D team with expertise in drug discovery such as compound discovery, drug efficacy evaluation, and clini... |
Reviews 0
